Haemonetics Announces European Expansion for VASCADE® Vascular Closure System
Retrieved on:
Tuesday, August 29, 2023
CE, EU, International, Gleneagles Global Hospitals, HAE, Back pain, Jewish Hospital (Cincinnati, Ohio), Hospital, Hemostasis, Cardiac catheterization, Medical director, Patient, Physician, Cardiology, EP, Haemonetics, MVP, European Medical Students' Association, NYSE, Pharmaceutical industry, Medical imaging, Electrophysiology
This marks the first use of the VASCADE system portfolio, widely used in U.S. hospitals, in a European country.
Key Points:
- This marks the first use of the VASCADE system portfolio, widely used in U.S. hospitals, in a European country.
- The VASCADE system is designed for "small-bore" femoral arterial and venous closure, generally used in interventional cardiology and peripheral vascular procedures.
- The VASCADE MVP system is designed for "mid-bore" multi-access femoral venous closure, generally used in electrophysiology procedures.
- Haemonetics is planning further expansion for the VASCADE system portfolio in other markets outside the U.S.